GL Pharm Tech Corp
KOSDAQ:204840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
GL Pharm Tech Corp
Total Equity
GL Pharm Tech Corp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GL Pharm Tech Corp
KOSDAQ:204840
|
Total Equity
₩20B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
9%
|
|
|
Yuhan Corp
KRX:000100
|
Total Equity
₩2.3T
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Equity
₩813B
|
CAGR 3-Years
37%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Equity
₩1.2T
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Equity
₩276B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Equity
₩212.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
GL Pharm Tech Corp
Glance View
GL Pharm Tech Corp. engages in the provision of pharmaceutical research and development services and in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-11-20.
See Also
What is GL Pharm Tech Corp's Total Equity?
Total Equity
20B
KRW
Based on the financial report for Sep 30, 2025, GL Pharm Tech Corp's Total Equity amounts to 20B KRW.
What is GL Pharm Tech Corp's Total Equity growth rate?
Total Equity CAGR 10Y
9%
Over the last year, the Total Equity growth was 2%. The average annual Total Equity growth rates for GL Pharm Tech Corp have been 8% over the past three years , 18% over the past five years , and 9% over the past ten years .
